Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

*Product:*	Panvax H5N8 pre-pandemic
Active Ingredient:	Influenza Virus Type A haemagglutinin 30mcg
Dosage Form:	Suspension for injection
New Zealand Sponsor:	Seqirus (NZ) Limited
Manufacturer:	Seqirus Pty Limited, Melbourne, Australia
Note: This consent is given subject to the following condition: The vaccine may only be marketed or distributed in accordance with the directives contained in the current version of the New Zealand Pandemic Plan.
Note: This consent is valid for two years from the date of publication of this notice.

Dated this 1st day of November 2024.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Provisional Consent to the Distribution of a New Medicine

Tags

Notice Number

Schedule